Covered recipient · General Payments record
JOHN ELLIOTT CHRISTIE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2021
$1,243.96
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $351.49 | 19 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $90.32 | 4 |
| Lilly USA, LLC | $62.07 | 4 |
| Biohaven Pharmaceuticals, Inc. | $61.81 | 4 |
| ABBVIE INC. | $51.22 | 3 |
| EISAI INC. | $43.68 | 2 |
| Novo Nordisk AS | $42.39 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $23.83 | 04/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794257951 | CMS |
| AbbVie Inc. | $11.33 | 04/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794257953 | CMS |
| AbbVie Inc. | $16.06 | 06/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794257955 | CMS |
| Amgen Inc. | $17.10 | 03/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825447247 | CMS |
| Amgen Inc. | $24.73 | 03/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825447253 | CMS |
| Amgen Inc. | $26.49 | 07/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825447235 | CMS |
| Amgen Inc. | $22.00 | 08/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825447241 | CMS |
| Biohaven Pharmaceuticals, Inc. | $14.09 | 01/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852461471 | CMS |
| Biohaven Pharmaceuticals, Inc. | $17.27 | 03/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852461475 | CMS |
| Biohaven Pharmaceuticals, Inc. | $14.25 | 08/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852461479 | CMS |
| Biohaven Pharmaceuticals, Inc. | $16.20 | 09/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852461483 | CMS |
| Eisai Inc. | $23.65 | 03/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 817870164 | CMS |
| Eisai Inc. | $20.03 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 817943663 | CMS |
| Lilly USA, LLC | $15.18 | 01/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818569127 | CMS |
| Lilly USA, LLC | $14.17 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819156437 | CMS |
| Lilly USA, LLC | $13.48 | 04/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818560343 | CMS |
| Lilly USA, LLC | $19.24 | 07/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818577861 | CMS |
| Novo Nordisk Inc | $21.05 | 02/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836095549 | CMS |
| Novo Nordisk Inc | $21.34 | 03/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836095551 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.